Page last updated: 2024-08-23

pirfenidone and Idiopathic Interstitial Pneumonia

pirfenidone has been researched along with Idiopathic Interstitial Pneumonia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Boulate, D; Crutu, A; Dauriat, G; Dolidon, S; Fabre, D; Fadel, E; Feuillet, S; Florea, V; Gazengel, P; Hanna, A; Le Pavec, J; Mercier, O; Mitilian, D; Mussot, S; Pradere, P1
Azuma, A; Bando, M; Ebina, M; Homma, S; Kudoh, S; Nukiwa, T; Sugiyama, Y; Taguchi, Y; Takahashi, H; Taniguchi, H1
Lota, HK; Wells, AU1

Reviews

2 review(s) available for pirfenidone and Idiopathic Interstitial Pneumonia

ArticleYear
Lung transplantation for idiopathic pulmonary fibrosis.
    Presse medicale (Paris, France : 1983), 2020, Volume: 49, Issue:2

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Cardiovascular Diseases; Comorbidity; Disease Progression; Frailty; Gastroesophageal Reflux; Humans; Hypertension, Pulmonary; Idiopathic Interstitial Pneumonias; Idiopathic Pulmonary Fibrosis; Indoles; Lung Neoplasms; Lung Transplantation; Prognosis; Pyridones; Telomere Shortening

2020
The evolving pharmacotherapy of pulmonary fibrosis.
    Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1

    Topics: Acetylcysteine; Anti-Inflammatory Agents, Non-Steroidal; Humans; Idiopathic Interstitial Pneumonias; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary; Scleroderma, Systemic; Treatment Outcome

2013

Other Studies

1 other study(ies) available for pirfenidone and Idiopathic Interstitial Pneumonia

ArticleYear
A prospective survey of idiopathic interstitial pneumonias in a web registry in Japan.
    Respiratory investigation, 2015, Volume: 53, Issue:2

    Topics: Aged; Female; Humans; Idiopathic Interstitial Pneumonias; Internet; Japan; Male; Middle Aged; Multicenter Studies as Topic; Prognosis; Prospective Studies; Pyridones; Registries; Survival Rate; Time Factors

2015